Respiratory Tract Diseases

590 trials 200 recruiting

Filter these 590 trials by phase, country and sponsor.

Open in Search →

TRACkER trial Ended

2023-508300-37-00 Chronic Obstructive Pulmonary Disease (COPD) 6
A Phase 2, Open-label, Multiple Ascending-Dose Study to Evaluate the Safety, Tolerability and Efficacy of ARCT-032 in People with Cystic Fib… Ended

2024-517663-23-01 Cystic Fibrosis 4
STRIDER: A phase II Study evaluaTing intRacranial effIcacy of JDQ443 in patiEnts with KRAS G12C+ NSCLC and bRain metastases Ended

2023-505721-13-00 patients with KRAS G12C+ non small cell lung cancer and 4
Beta-blockeRs tO patieNts with CHronIc Obstructive puLmonary diseasE (BRONCHIOLE) Ended

2024-512407-39-00 Chronic obstructive pulmonary disease 6
A study to investigate the similarity of two different Tiotropium inhalers in healthy volunteers. Ended

2023-509025-41-00 No therapeutic indication in the current trial with hea 2
Efficacy and safety of the intratracheal administration of budesonide with surfactant in very preterm infants to prevent bronchopulmonary dy… Ended

2024-519980-16-00 Bronchopulmonary dysplasia 5
Pembrolizumab Alone versUs pembrolizumab-chemotherapy in first LInE NSCLC (PAULIEN) Ended

2024-516581-11-00 Advanced stage NSCLC 5
A double-blind, placebo-controlled, parallel-group study to evaluate the safety and efficacy of briquilimab in participants with allergic a… Ended

2024-516164-28-00 allergic asthma 3
A Phase 1/2 Study of NTLA-3001 in Adults with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease Ended

2023-508138-33-00 Pulmonary emphysema 7
Metoprolol in Acute Respiratory Distress Syndrome (MAIDEN) Ended

2024-515813-17-00 Acute Respiratory Distress Syndrome (ARDS) 5
A randomized controlled trial of two adjunctive host-directed therapies in rifampin-resistant tuberculosis (DRTB-HDT). Ended

2025-520745-80-00 Multidrug rezistant pulmonary tuberculosis 4
Immune responses in health care personnel Ended

2024-515372-12-00 Influenza, Immunity against influenza 6
A trial to find out how well CVHNLC works at different dose levels and how safe it is in combination with pembrolizumab in patients with lun… Ended

2024-519651-28-00 metastatic squamous non-small cell lung cancer 1
Nebulised RESP30X Nitric Oxide Formulations in NCFB Patients with Pseudomonas Aeruginosa (Pa) (NOPA) Ended

2023-508706-23-00 Non-Cystic Fibrosis Bronchiectasis with Pseudomonas Aer 9